TipRanks
Traws Pharma (DE:0T20)
FRANKFURT:0T20
Germany Market
0T20
Traws Pharma
RESEARCH TOOLSreports

Traws Pharma (0T20) Income Statement

1 Followers

Traws Pharma Income Statement

Last quarter (Q2 2026), Traws Pharma's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q2, Traws Pharma's net income was $-3.05M. See Traws Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 2.79M$ 226.00K$ 226.00K$ 226.00K$ 226.00K
Gross Profit
$ 2.79M$ 214.00K$ 226.00K$ 226.00K$ 226.00K
Operating Expenses
$ 20.66M$ 49.56M$ 20.52M$ 19.85M$ 16.72M
Depreciation and Amortization
$ 61.00K$ 12.00K$ 16.00K$ 14.00K$ 14.00K
EBITDA
$ -17.81M$ -166.51M$ -20.28M$ -19.61M$ -16.48M
Operating Income
$ -17.88M$ -49.35M$ -20.30M$ -19.63M$ -16.50M
Other Income/Expenses
$ 27.05M$ -117.17M$ 1.35M$ 663.00K$ 333.00K
Pretax Income
$ 9.17M$ -166.52M$ -18.95M$ -18.96M$ -16.16M
Net Income
$ 9.17M$ -54.67M$ -18.95M$ -18.96M$ -16.16M
Per Share Metrics
Basic EPS
$ 0.83$ -35.21$ -22.57$ -22.68$ -24.01
Diluted EPS
$ 0.82$ -35.21$ -22.57$ -22.68$ -24.01
Weighted Average Shares Outstanding
 8.23M 1.55M 839.55K 836.33K 673.29K
Weighted Average Shares Outstanding (Diluted)
 8.38M 1.55M 839.55K 836.33K 673.29K
Currency in USD

Traws Pharma Earnings and Revenue History